Company intelligence / Profile preview

ChemGenes

Wilmington, Massachusetts, United Stateschemgenes.com ↗

Ownership: Private
Development stage: Commercial

Overview

ChemGenes supplies a broad range of high-purity reagents and building blocks essential for DNA/RNA synthesis. Their products are widely used in the development of diagnostics, therapeutics—including those used in COVID‑19 vaccines—and academic research. The company has a strong reputation as a market leader with decades of experience supporting life science innovation globally[1][3][4][5].

Modalities: Synthetic oligonucleotideAntisense oligonucleotideSmall molecule (reagents for DNA/RNA synthesis)
Industry: Chemicals & Materials

Partnerships

Not specifically listed; partners include pharmaceutical companies, biotech firms, academic institutions worldwide

Beyond the preview

Go deeper on ChemGenes.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ChemGenes.

Explore the full profile